SCHEMBL369581

SCHEMBL369581

Cc1cc(Cl)ccc1C(CC(=O)c1ccc(=O)n(C)c1)c1ccc(C(=O)O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.40
CREBBP Q92793 1/20 0.40
PTGER4 P35408 1/20 0.37
PTGDR Q13258 1/20 0.37
CYP2C9 P11712 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
CYP2C19 P33261 1/20 0.37
MGAM O43451 2/20 0.36
GAA P10253 2/20 0.36
SI P14410 2/20 0.36
MGAM2 Q2M2H8 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PHGDH O43175 1/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
F11 P03951 2/20 0.36
PRKCZ Q05513 1/20 0.35
KLKB1 P03952 1/20 0.35
GPBAR1 Q8TDU6 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL371309 0.93 POLB (0.40) POLBCREBBPCYP2C9KMT2AMEN1
SCHEMBL369750 0.92 POLB (0.40) POLBCREBBPCYP2C9KMT2AMEN1
SCHEMBL368816 0.92 KMT2A (0.46) POLBCREBBPCYP2C9KMT2AMEN1
SCHEMBL15832896 0.92 POLB (0.39) POLBCREBBPCYP2C9KMT2AMEN1
SCHEMBL370765 0.91 CYP2C9 (0.39) POLBCREBBPCYP2C9KMT2AMEN1
SCHEMBL1390419 0.90 LMNA (0.43) POLBCREBBPCYP2C9KMT2AMEN1
SCHEMBL370157 0.89 GPBAR1 (0.39) POLBCYP2C9CYP2C19MGAMGAA
Formic Acid SCHEMBL27924258 0.89 BRD4 (0.39) POLBCREBBPKMT2AMEN1MGAM
SCHEMBL369536 0.88 POLB (0.38) POLBCREBBPCYP2C9KMT2AMEN1
SCHEMBL1390512 0.88 CHRNA7 (0.37) POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 POLB 2940/4885CREBBP 2198/4885PTGER4 103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.